阿奇霉素序贯疗法治疗小儿支原体肺炎的临床疗效研讨

Clinical Effect of Sequential Azithromycin Therapy on Mycoplasma Pneu⁃monia in Children

目的分析支原体肺炎患儿实施阿奇霉素序贯治疗的效果。方法选取2022年10月—2023年10月江阴市人民医院收治的80例支原体肺炎患儿作为研究对象,随机分为参考组(行传统治疗)和探究组(行阿奇霉素序贯治疗),各40例。比较两组患儿治疗总有效率、炎症指标、肺功能、不良反应发生率。结果治疗前,两组患儿的炎症指标、肺功能比较差异无统计学意义(P均>0.05);治疗后,探究组治疗总有效率、肺功能指标水平均高于参考组,炎症指标、不良反应发生率均低于参考组,差异有统计学意义(P均<0.05)。结论阿奇霉素序贯治疗安全性高,能迅速减轻炎症,提升肺功能,疗效显著。

Objective To analyze the effect of sequential treatment with azithromycin in children with mycoplasma pneumonia.Methods A total of 80 children with mycoplasma pneumonia treated in Jiangyin People's Hospital from October 2022 to October 2023 were selected as the study objects,and were randomly divided into reference group(re⁃ceiving traditional treatment)and inquiry group(receiving sequential treatment with azithromycin),with 40 cases in each group.The total treatment effectiveness,inflammation index,lung function and incidence of adverse reactions were compared between the two groups of children patients.Results Before treatment,there were no significant differ⁃ences in inflammatory indexes and lung function between the two groups(both P>0.05);after treatment,the total treat⁃ment effective rate and lung function of the exploration group were higher than those of the reference group,and the in⁃flammatory indicators and the incidence of adverse reactions were lower than those of the reference group,and the dif⁃ferences were statistically significant(all P<0.05).Conclusion The sequential treatment of azithromycin has high safety,can rapidly reduce inflammation,improve lung function,and have significant the effectiveness.